期刊
OBESITY REVIEWS
卷 18, 期 10, 页码 1147-1158出版社
WILEY
DOI: 10.1111/obr.12567
关键词
Interleukin-15; obesity; type 2 diabetes mellitus
资金
- National Basic Research Program of China [2013CB127305]
- Nature Science Foundation of Hunan Province [S2014J504I]
- Youth Innovation Promotion Association CAS [2016326]
- Major Project of Hunan Province [2015NK1002]
- Key Project of Research and Development Plan of Hunan Province [2016NK2170]
- Youth Innovation Team Project of ISA, CAS [2017QNCXTD_ZCS]
Obesity rises rapidly and is a major health concern for modern people. Importantly, it is a major risk factor in the development of numerous chronic diseases such as type 2 diabetes mellitus (T2DM). Recently, interleukin (IL)-15 has attracted considerable attention as a potential regulator for the prevention and/or treatment of obesity and T2DM. The beneficial effects include increased loss of fat mass and body weight, improved lipid and glucose metabolism, reduced white adipose tissue inflammation, enhanced mitochondrial function, alterations in the composition of muscle fibres and gut bacterial and attenuated endoplasmic reticulum stress. Although these beneficial effects are somewhat controversial, IL-15, exogenously delivered or endogenously produced, may be a promising target in the prevention and treatment of obesity and T2DM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据